查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1675361

2025 年至 2033 年黏弹性补充剂市场按类型、年龄层、配销通路、应用、最终用途和地区划分

Viscosupplementation Market by Type, Age Group, Distribution Channel, Application, End Use, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

2024IMARC Group全球黏液补充剂市场规模达到 48 亿美元。骨质疏鬆症和骨关节炎（OA）盛行率的不断上升，以及消费者越来越倾向于微创非手术治疗，是推动市场发展的一些关键因素。

黏弹性补充疗法是一种微创医疗程序，其中将包含凝胶状液体（称为外源性液压酸 (HA) 衍生物）的关节内注射直接注射到患者的膝关节中。它充当润滑剂，使骨骼能够彼此顺利移动，减轻炎症，并充当关节负荷的减震器。黏弹性补充疗法可减少运动过程中的摩擦，帮助滑液形成更多的缓衝，消除剧烈疼痛，并增强关节的活动范围。除此之外，它还能恢復滑液的流变特性，产生机械、镇痛、抗发炎和软骨保护作用。因此，黏弹性补充疗法广泛应用于膝关节、髋关节和手部骨关节炎的治疗。目前主要有中、低、高分子量。

黏液补充市场趋势：

骨质疏鬆症和骨关节炎（OA）盛行率的不断上升是推动市场成长的关键因素之一。同时，消费者越来越倾向于微创非手术治疗方案，这促进了医疗保健领域广泛采用黏弹性补充剂来治疗皮质类固醇和关节疼痛。这反过来又成为另一个重要的成长诱导因素。这进一步受到消费者对非手术治疗的多种益处的认识不断提高的影响，包括无需住院、费用更少、并发症更少、临床结果和恢復率更好。此外，政府的优惠措施和各製药公司为推出新药和不同给药途径而进行的大量投资也支持了市场的成长。此外，提供强化治疗以解决关节、韧带、肌肉、脊椎和神经等身体各部位的手术和非手术问题的门诊手术中心 (ACS) 的出现有利于市场的成长。此外，含有液压酸的开放标籤单次注射剂的推出正在推动市场成长。除此之外，优惠的健康保险报销政策、易患慢性疾病的老年人口不断增加、慢性残疾人数量不断增加、主要参与者之间的合作与伙伴关係以及医学科学领域的持续研发活动都对市场增长产生了积极影响。

本报告回答的关键问题：

  • 到目前为止，全球黏液补充市场表现如何？
  • 全球黏液补充市场有哪些驱动因素、限制因素和机会？
  • 主要的区域市场有哪些？
  • 哪些国家拥有最具吸引力的黏液补充市场？
  • 根据类型，市场区隔是怎样的？
  • 根据年龄段，市场如何分布？
  • 根据配销通路，市场如何划分？
  • 根据应用，市场区隔是怎样的？
  • 根据最终用途，市场如何划分？
  • 全球黏液补充市场的竞争结构是怎么样的？
  • 全球黏液补充市场的主要参与者/公司有哪些？

目录

第 1 章：前言

第 2 章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球黏弹性补充市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第六章：市场细分：依类型

  • 单次注射
  • 三次注射
  • 五次注射

第七章：市场区隔：依年龄段

  • 成年人
  • 老年病学

第 8 章：市场区隔：按配销通路

  • 医院药房
  • 零售药局
  • 网路药局

第 9 章：市场区隔：按应用

  • 膝关节骨关节炎
  • 髋关节骨关节炎
  • 手部骨关节炎
  • 其他的

第 10 章：市场区隔：最终用途别

  • 医院
  • 骨科诊所
  • 其他的

第 11 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第 12 章：驱动因素、限制因素与机会

  • 概述
  • 驱动程式
  • 限制
  • 机会

第 13 章：价值链分析

第 14 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 15 章：价格分析

第 16 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Anika Therapeutics Inc.
    • Aptissen SA
    • Bioventus LLC
    • Ferring Pharmaceuticals
    • Fidia Farmaceutici SpA
    • Johnson & Johnson
    • LG Chem Ltd.
    • OrthogenRx Inc. (Avanos Medical Inc.)
    • Sanofi SA
    • Seikagaku Corporation
    • Virchow Biotech Private Limited
    • Zimmer Biomet
    • Zuventus HealthCare Ltd. (Emcure Pharmaceuticals Limited)
Product Code: SR112025A6931

The global viscosupplementation market size reached USD 4.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 9.1 Billion by 2033, exhibiting a growth rate (CAGR) of 7.05% during 2025-2033. The increasing prevalence of osteoporosis and osteoarthritis (OA) and the shifting consumer inclination toward minimally invasive non-surgical treatments represent some of the key factors driving the market.

Viscosupplementation represents a minimally invasive medical procedure wherein intraarticular injection comprising gel-like fluid known as exogenous hydraulic acid (HA) derivatives are directly administered into the knee joints of the patient. It acts as a lubricant, which enables bones to move smoothly over each other, lowers inflammation, and performs as a shock absorber for joint loads. Viscosupplementation reduces the friction during the movements, assists the synovial fluids in creating more cushion, eliminates severe pain, and enhances the range of movements or motions of the joint. Apart from this, it restores the rheological properties of the synovial fluids, which produce mechanical, analgesic, anti-inflammatory, and chondroprotective effects. As a result, viscosupplementation is extensively utilized in the treatment of knee, hip, and hand osteoarthritis. Currently, it is mainly available in intermediate, low, and high molecular weights.

Viscosupplementation Market Trends:

The increasing prevalence of osteoporosis and osteoarthritis (OA) represents one of the key factors driving the market growth. In line with this, the shifting consumer inclination toward the minimally invasive non-surgical treatment options has facilitated the widespread adoption of viscosupplementation in the healthcare sector for corticosteroids and joint pain management. This, in turn, is acting as another major growth-inducing factor. This is further influenced by the growing consumer awareness regarding the multiple benefits of non-surgical treatments, including no hospitalization, fewer expenses, minimal complications, and better clinical outcomes and recovery rates. Additionally, the favorable government initiatives and significant investments by various pharmaceutical companies to launch novel drugs and different routes of administrations is supporting the market growth. Moreover, the emergence of ambulatory surgical centers (ACS) that offer intensive treatment to resolve surgical and non-surgical problems in various body parts, such as joints, ligaments, muscle, spine, and nerves, is favoring the market growth. Furthermore, the introduction of open-label single-injections with hydraulic acid is propelling the market growth. Apart from this, favorable health insurance reimbursement policies, the rising geriatric population, which is susceptible to chronic ailments, increasing number of individuals with chronic disability, collaborations and partnership among the key players, and continuous research and development (R&D) activities in the field of medical sciences are positively impacting the market growth.

Key Market Segmentation:

Type Insights:

  • Single Injection
  • Three Injection
  • Five Injection
  • The report has also provided a detailed breakup and analysis of viscosupplementation market based on the type. This includes single, three and five injection. According to the report, single injection represented the largest segment.

Age Group Insights:

  • Adults
  • Geriatrics

Distribution Channel Insights:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • The report has also provided a detailed breakup and analysis of viscosupplementation market based on the distribution channel. This includes hospital, retail and online pharmacies. According to the report, hospital pharmacies represented the largest segment.

Application Insights:

  • Knee Osteoarthritis
  • Hip Osteoarthritis
  • Hand Osteoarthritis
  • Others

End Use Insights:

  • Hospitals
  • Orthopedic Clinics
  • Others
  • The report has also provided a detailed breakup and analysis of viscosupplementation market based on the end use. This includes hospitals, orthopedic clinics, and others. According to the report, orthopedic clinics represented the largest segment.

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, the North America was the largest market for viscosupplementation. Some of the factors driving the North America viscosupplementation market included the rising geriatric population and the affordable health insurance reimbursement policies.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global viscosupplementation market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Anika Therapeutics Inc., Aptissen S.A., Bioventus LLC, Ferring Pharmaceuticals, Fidia Farmaceutici S.p.A., Johnson & Johnson, LG Chem Ltd., OrthogenRx Inc. (Avanos Medical Inc.), Sanofi S.A., Seikagaku Corporation, Virchow Biotech Private Limited, Zimmer Biomet, Zuventus HealthCare Ltd. (Emcure Pharmaceuticals Limited), etc.

Key Questions Answered in This Report:

  • How has the global viscosupplementation market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global viscosupplementation market?
  • What are the key regional markets?
  • Which countries represent the most attractive viscosupplementation markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the age group?
  • What is the breakup of the market based on the distribution channel?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end use?
  • What is the competitive structure of the global viscosupplementation market?
  • Who are the key players/companies in the global viscosupplementation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Viscosupplementation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Single Injection
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Three Injection
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Five Injection
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Age Group

  • 7.1 Adults
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Geriatrics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Knee Osteoarthritis
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hip Osteoarthritis
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Hand Osteoarthritis
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by End Use

  • 10.1 Hospitals
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Orthopedic Clinics
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 Drivers, Restraints, and Opportunities

  • 12.1 Overview
  • 12.2 Drivers
  • 12.3 Restraints
  • 12.4 Opportunities

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Anika Therapeutics Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Aptissen S.A.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 Bioventus LLC
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
    • 16.3.4 Ferring Pharmaceuticals
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Fidia Farmaceutici S.p.A.
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 Johnson & Johnson
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
      • 16.3.6.4 SWOT Analysis
    • 16.3.7 LG Chem Ltd.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 OrthogenRx Inc. (Avanos Medical Inc.)
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 Sanofi S.A.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Seikagaku Corporation
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
    • 16.3.11 Virchow Biotech Private Limited
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
    • 16.3.12 Zimmer Biomet
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis
    • 16.3.13 Zuventus HealthCare Ltd. (Emcure Pharmaceuticals Limited)
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Viscosupplementation Market: Major Drivers and Challenges
  • Figure 2: Global: Viscosupplementation Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Viscosupplementation Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Viscosupplementation Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Viscosupplementation Market: Breakup by Age Group (in %), 2024
  • Figure 6: Global: Viscosupplementation Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Viscosupplementation Market: Breakup by Application (in %), 2024
  • Figure 8: Global: Viscosupplementation Market: Breakup by End Use (in %), 2024
  • Figure 9: Global: Viscosupplementation Market: Breakup by Region (in %), 2024
  • Figure 10: Global: Viscosupplementation (Single Injection) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Viscosupplementation (Single Injection) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Viscosupplementation (Three Injection) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Viscosupplementation (Three Injection) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Viscosupplementation (Five Injection) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Viscosupplementation (Five Injection) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Viscosupplementation (Adults) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Viscosupplementation (Adults) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Viscosupplementation (Geriatrics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Viscosupplementation (Geriatrics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Viscosupplementation (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Viscosupplementation (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Viscosupplementation (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Viscosupplementation (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Viscosupplementation (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Viscosupplementation (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Viscosupplementation (Knee Osteoarthritis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Viscosupplementation (Knee Osteoarthritis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Viscosupplementation (Hip Osteoarthritis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Viscosupplementation (Hip Osteoarthritis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Viscosupplementation (Hand Osteoarthritis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Viscosupplementation (Hand Osteoarthritis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Viscosupplementation (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Viscosupplementation (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Viscosupplementation (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Viscosupplementation (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Viscosupplementation (Orthopedic Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Viscosupplementation (Orthopedic Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Global: Viscosupplementation (Other End Uses) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Global: Viscosupplementation (Other End Uses) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: North America: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: North America: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: United States: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: United States: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Canada: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Canada: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Asia-Pacific: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Asia-Pacific: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: China: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: China: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Japan: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Japan: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: India: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: India: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: South Korea: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: South Korea: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Australia: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Australia: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Indonesia: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Indonesia: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Others: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Others: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Europe: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Europe: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Germany: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Germany: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: France: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: France: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: United Kingdom: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: United Kingdom: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Italy: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Italy: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Spain: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Spain: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Russia: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Russia: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Others: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Others: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Latin America: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Latin America: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Brazil: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Brazil: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Mexico: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Mexico: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Others: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Others: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Middle East and Africa: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 87: Middle East and Africa: Viscosupplementation Market: Breakup by Country (in %), 2024
  • Figure 88: Middle East and Africa: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Global: Viscosupplementation Industry: Drivers, Restraints, and Opportunities
  • Figure 90: Global: Viscosupplementation Industry: Value Chain Analysis
  • Figure 91: Global: Viscosupplementation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Viscosupplementation Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Viscosupplementation Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Viscosupplementation Market Forecast: Breakup by Age Group (in Million USD), 2025-2033
  • Table 4: Global: Viscosupplementation Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Viscosupplementation Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 6: Global: Viscosupplementation Market Forecast: Breakup by End Use (in Million USD), 2025-2033
  • Table 7: Global: Viscosupplementation Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 8: Global: Viscosupplementation Market: Competitive Structure
  • Table 9: Global: Viscosupplementation Market: Key Players